CC BY-NC-ND 4.0 · Indian J Radiol Imaging 2017; 27(01): 82-87
DOI: 10.4103/0971-3026.202956
Interventional Radiology

Role of penumbra mechanical thrombectomy device in acute dural sinus thrombosis

Suraj Mammen
Department of Radiology, Christian Medical College, Vellore, Tamil Nadu, India
,
Shyamkumar Nidugala Keshava
Department of Radiology, Christian Medical College, Vellore, Tamil Nadu, India
,
Vinu Moses
Department of Radiology, Christian Medical College, Vellore, Tamil Nadu, India
,
Sanjith Aaron
Department of Neurology, Christian Medical College, Vellore, Tamil Nadu, India
,
Munawwar Ahmed
Department of Radiology, Christian Medical College, Vellore, Tamil Nadu, India
,
George K Chiramel
Department of Radiology, Christian Medical College, Vellore, Tamil Nadu, India
,
Sunithi E Mani
Department of Radiology, Christian Medical College, Vellore, Tamil Nadu, India
,
Mathew Alexander
Department of Neurology, Christian Medical College, Vellore, Tamil Nadu, India
› Author Affiliations
Financial support and sponsorship Nil.

Abstract

Background: In dural venous sinus thrombosis (DVST), the mortality ranges 5–30%. Deep venous system involvement and septic dural sinus thrombosis have a higher mortality rate. In acute occlusion, collateral flow may not be established, which may result in significant edema and mass effect. Endovascular interventions may be considered as a treatment option in appropriate high-risk patients with DVST. Materials and Methods: Eight patients with magnetic resonance imaging (MRI)-confirmed dural sinus thrombosis, who did not respond to the conventional standard medical treatment, were subsequently treated with mechanical thrombectomy using the Penumbra System®. In all cases, medical treatment including anticoagulants were continued following the procedure for a minimum period of 1 year. Results: Recanalization of the dural sinus thrombosis was achieved in all 8 cases. There were no immediate or late endovascular-related complications. One death occurred due to an unrelated medical event. At 6 months, there was notable improvement in the modified Rankin Score (mRS), with 5/8 (62%) patients achieving mRS of 2 or less. The follow-up ranged between 3 months and 26 months (mean: 14.5 months), and there were no new neurological events during the follow-up period. Conclusion: Cerebral venous sinus thrombosis is a rare but life-threatening condition that demands timely diagnosis and therapy. In cases of rapidly declining neurological status despite standard therapy with systemic anticoagulation and anti-edema measures, mechanical thrombectomy could be a lifesaving and effective option. In this study, good outcomes were observed in the majority of patients at long-term follow up.



Publication History

Article published online:
27 July 2021

© 2017. Indian Radiological Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 
  • References

  • 1 Medel R, Monteith JS, Crowley WR, Dumont SA. A review of therapeutic strategies for the management of cerebral venous sinus thrombosis. Neurosurg Focus 2009;27:E6.
  • 2 Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F; ISCVT Investigators. Prognosis of cerebral vein and dural sinus thrombosis: Results of the International Study on Cerebral Vein and Dural Sinus Thrombosis. Stroke 2004;35:664-70.
  • 3 Chow K, Gobin YP, Saver J, Kidwell C, Dong P, Viñuela F. Endovascular Treatment of Dural Sinus Thrombosis With Rheolytic Thrombectomy and Intra-Arterial Thrombolysis. Stroke 2000;31:1420-5.
  • 4 Bentley NJ, Figueroa ER, Vender RJ. From presentation to follow-up: Diagnosis and treatment of cerebral venous thrombosis. Neurosurg Focus 2009;27:E4.
  • 5 Aaron S, Alexander M, Moorthy RK, Mani S, Mathew V, Patil AK, et al. Decompressive craniectomy in cerebral venous thrombosis: A single centre experience Neurol Neurosurg Psychiatry 2013;84:995-1000.
  • 6 Choulakian A, Alexander MJ. Mechanical thrombectomy with the penumbra system for treatment of venous sinus thrombosis. J Neurointerv Surg 2010;2:153-6.
  • 7 Gerszten PC, Welch WC, Spearman MP, Jungreis CA, Redner RL. Isolated deep cerebral venous thrombosis treated by direct endovascular thrombolysis. Surg Neurol 1997;48:261-6.
  • 8 Rahman M, Velat JG, Hoh BL, Mocco J. Direct thrombolysis for cerebral venous sinus thrombosis. Neurosurg Focus 2009;27:E7.
  • 9 Mohammadian R, Sohrabi B, Mansourizadeh R, Mohammadian F, Nazempour A, Farhoudi M, et al. Treatment of Progressive Cerebral Sinuses Thrombosis with Local Thrombolysis. Interv Neuroradiol 2012;18:89-96.
  • 10 Dentali F, Squizzato A, Gianni M, De Lodovici ML, Venco A, Paciaroni M, et al. Safety of thrombolysis in cerebral venous thrombosis. A systematic review of the literature. Thromb Haemost 2010;104:1055-62.
  • 11 Siddiqui FM, Banerjee C, Zuurbier SM, Hao Q, Ahn C, Pride GL, et al. Mechanical Thrombectomy versus Intrasinus Thrombolysis for Cerebral Venous Sinus Thrombosis: A Non-Randomized Comparison. Interv Neuroradiol 2014;20:336-44.
  • 12 Penumbra Pivotal Stroke Trial Investigators. The Penumbra pivotal stroke trial I: Safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009;40:2761-8.